Jones FC, Grabherr MG, Chan YF, Russell P, Mauceli E, Johnson J, et al. The genomic basis of adaptive evolution in threespine sticklebacks. Nature. 2012;484(7392):55–61.
Kjærner-Semb E, Ayllon…

Jones FC, Grabherr MG, Chan YF, Russell P, Mauceli E, Johnson J, et al. The genomic basis of adaptive evolution in threespine sticklebacks. Nature. 2012;484(7392):55–61.
Kjærner-Semb E, Ayllon…
A few days ago, the International Iberian Nanotechnology Laboratory (INL) and University of Minho (UMinho) signed a licensing agreement with IPLEXMED, a spin-out company specializing in advanced medical diagnostics. The agreement grants the…

Alstom (ENXTPA:ALO) shares have shown some movement recently, with the stock delivering a 4% gain in the past day and 13% in the past week. Investors may be watching these changes for early signs of shifting momentum or trends in the stock’s valuation.
See our latest analysis for Alstom.
Alstom’s recent rally stands out against a backdrop of more modest moves earlier this year, with the 1-year total shareholder return at just over 4%. While fresh momentum is evident in the last week, this follows a tougher multi-year stretch for shareholders.
If you’re curious to see what else is building momentum in industrials, it’s worth taking a look at the full lineup of auto manufacturers. See the full list for free.
With Alstom’s shares rising and a recent uptick in revenue and net income, the question for investors is clear: is there real value left to uncover here, or has the market already priced in all the future growth?
The consensus narrative’s fair value estimate of €23.06 is just under Alstom’s latest close at €23.69, suggesting little upside in the eyes of analysts right now. The story behind that estimate combines future growth drivers, operational improvements, and optimism around Alstom’s project pipeline, balanced by caution regarding legacy challenges.
The company is conducting industrial restructuring to optimize its manufacturing setup, which aims to enhance operational efficiency and potentially improve net margins and earnings. Significant future opportunities lie in Alstom’s strong order pipeline, especially in Europe, the Middle East, and Asia Pacific, with €200 billion expected in orders over the next three years, which could enhance revenue.
Read the complete narrative.
What’s the quantitative backbone for this call on Alstom? Analysts have run the numbers on revenue trajectories, margin expansion, and some big earnings assumptions to frame their target. Wondering how bold their scenario is, and what key variable makes or breaks this price? Read the full narrative and uncover the forecast that drives this valuation.
Result: Fair Value of €23.06 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, persistent supply chain issues and the weight of low-margin legacy contracts could quickly change the outlook for Alstom’s growth story.
Find out about the key risks to this Alstom narrative.
If you want to dig into the numbers yourself or have a different view on the future, you can quickly piece together your own story in just a few minutes using our tools. Do it your way.

Evolv Technologies Holdings (EVLV) has seen some movement in its share price recently, leaving investors wondering how the current valuation compares to past performance. A quick look at recent returns raises some interesting points for consideration.
See our latest analysis for Evolv Technologies Holdings.
After a rapid run-up earlier this year, Evolv Technologies Holdings is now experiencing a noticeable pullback with the share price down 27.4% over the past month. Still, momentum remains positive in the bigger picture, as the year-to-date share price return stands at 51.1% and the 1-year total shareholder return is a remarkable 132.6%. This underscores strong long-term performance even as some recent gains have cooled off.
If Evolv’s volatility has you wondering what else could offer big upside, consider broadening your search and discover fast growing stocks with high insider ownership
With the stock now trading 35% below analyst targets after steep gains and brisk growth, investors must ask if Evolv Technologies Holdings is undervalued at these levels or if the market has already priced in its future potential.
The most widely followed narrative suggests Evolv Technologies Holdings’ fair value sits comfortably above the last close of $6.00. This makes the current markdown look compelling against future expectations. Investors have noticed the gap between ambitious growth plans and the company’s discounted share price, which sets the stage for a deeper look at what is fueling these forecasts.
The company’s pivot away from channel/distribution sales to more direct subscription and direct purchase models raises ARR per unit and enhances customer relationships. This is expected to drive higher recurring revenues, improved gross profit dollars, and greater pricing power over time.
Read the complete narrative.
Want to see what’s behind this valuation surge? The narrative hinges on expansion into new sectors, bigger recurring revenue streams, and an aggressive profit margin rebound. Intrigued? Find out which bold projections could be turning aggressive price targets into reality, but only if you explore the full story.
Result: Fair Value of $9.50 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, substantial upfront costs and any slowdown in customer expansion could quickly put pressure on profitability and cast doubt on bullish analyst projections.
Find out about the key risks to this Evolv Technologies Holdings narrative.
If you have a different angle or want to dig into the numbers yourself, you can craft a personalized outlook for Evolv Technologies Holdings in just a few minutes, so why not Do it your way

Proto Labs (PRLB) has ramped up its U.S. manufacturing footprint, unveiling a major expansion in Raleigh to meet growing demand for metal 3D-printed parts. The move brings upgraded capacity and specialized industry certifications.
See our latest analysis for Proto Labs.
While Proto Labs’ manufacturing expansion is making headlines, investors have already seen some momentum, with a robust 25% year-to-date share price return and an impressive 29% total shareholder return over the past year. These gains suggest that confidence may be building around the company’s future prospects following its strategic moves, even if long-term results remain mixed.
If Proto Labs’ latest growth push has you curious about what other innovators are gaining ground, why not explore See the full list for free. as your next discovery opportunity?
With expansion-driven optimism, a positive one-year total return, and a stock price still trading below analyst targets, the key question is whether Proto Labs offers genuine value or if growth prospects are already reflected in the current share price.
Proto Labs’ most widely followed narrative places fair value at $53.33, nearly 9% above the last close of $48.50. The gap is drawing attention to what is driving analyst conviction in upcoming growth and margins.
Ongoing investments in sales enablement, marketing, and optimization of fulfillment channels are improving customer experience and wallet share, evidenced by higher revenue per customer (+11% y/y) and increased cross-platform adoption (+44% y/y), which points to future top-line growth and improved earnings quality.
Read the complete narrative.
Curious which growth levers analysts believe will catapult Proto Labs above today’s stock price? One critical bet here is not just revenue expansion, but a transformation in profitability and market reach that could surprise skeptics. Catch the underlying math and market logic fueling the fair value, just one click away.
Result: Fair Value of $53.33 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, ongoing weakness in European manufacturing and reliance on a handful of large accounts could undermine Proto Labs’ anticipated growth if these trends worsen.
Find out about the key risks to this Proto Labs narrative.
On the other hand, Proto Labs trades at a steep price-to-earnings ratio of 77.4x. This is much higher than the US Machinery industry average of 24.1x and the peer group’s 32.8x. The fair ratio suggests the market could eventually move toward 32.8x, highlighting valuation risk if expectations reset.


ReutersOne of London’s most prestigious performing arts venues has introduced demand-led ticket pricing in a bid to “maximise” its revenue.
The Royal Ballet and Opera…

During this period, the Moon reaches its new…

It’s a campaign that’s flown by, beginning with a hugely credible, and largely unexpected, draw in Copenhagen in September. Scotland’s resilience was evident that night.
Angus Gunn had not played a club game since May. Lewis Ferguson had been an…

Antonio Fuoco converted his first-place start into the FIA GT World Cup Qualification Race win to secure…